Neutrophil attractant protein-1 and monocyte chemoattractant protein-1 in human serum. Effects of intravenous lipopolysaccharide on free attractants, specific IgG autoantibodies and immune complexes.
We recently found that normal human sera contain IgG antibodies against two chemoattractants, neutrophil attractant protein-1 (NAP-1/IL-8) and monocyte chemoattractant protein-1 (MCP-1), as well as immune complexes of these proteins. Intravenously administered LPS was reported to cause a sharp rise in serum NAP-1 concentration. Our study was designed to determine if LPS also caused an increase in MCP-1 and to measure associated changes in concentrations of antibody and immune complex. LPS caused a rise to peak within 2 to 3 h in serum concentrations of free NAP-1 and MCP-1, followed by an almost equally rapid fall toward base-line levels by about 5 h postinjection. MCP-1 concentration in sera from the 11 subjects rose to a peak of 330 +/- 52 pM. The peak value for NAP-1 was 80 +/- 11 pM. In 10 of the 11 subjects, free IgG autoantibody to MCP-1 decreased from a mean pre-LPS value of 1820 +/- 660 pM to a mean low of 53% of the respective initial values. Corresponding data for IgG anti-NAP-1 were a pre-LPS concentration of 216 +/- 7 pM, which decreased to a mean low of 44% of the respective initial values. The finding in some subjects of a rapid rise in free antibody after the nadir suggests the possibility of acute regulation of autoantibody secretion rates. Although the results suggested that LPS-induced chemoattractant combined with free antibody, serum concentrations of MCP-1-IgG or NAP-1-IgG did not increase, which points to an as yet unknown mechanism for trapping and elimination of the immune complexes.
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp, National Cancer Institute-Frederick Cancer Research and Development Center, MD.
I
I
Sylvester
A F
AF
Suffredini
A J
AJ
Boujoukos
G D
GD
Martich
R L
RL
Danner
T
T
Yoshimura
E J
EJ
Leonard
D000328:Adult; D000936:Antigen-Antibody Complex / Q000378:metabolism*; D001323:Autoantibodies / Q000097:blood*; D018932:Chemokine CCL2; D002630:Chemotactic Factors / Q000378:metabolism*; D005260:Female; D006706:Homeostasis; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism; D016209:Interleukin-8 / Q000097:blood*; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008297:Male
D000936:Antigen-Antibody Complex; D001323:Autoantibodies; D018932:Chemokine CCL2; D002630:Chemotactic Factors; D007074:Immunoglobulin G; D016209:Interleukin-8; D008070:Lipopolysaccharides